FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.

Johnson & Johnson's stock has seen modest gains in recent months. Read why I downgrade JNJ stock from buy to hold.

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

Metal stocks traded higher, with JSW Steel, Hindalco and Tata Steel climbing 2-3 percent on China stimulus hopes. Reliance Power jumped 5 percent after its board approved a prefer ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, fund raising and appointments, here’s a quick look at which stocks will be in focus in today's ...

Current treatment for SLE relies on old drugs like hydroxychloroquine and corticosteroids, although the armamentarium has ...

Several launches in 2027 (Amgen, Altimmune), 2028 (Pfizer, Roche, Viking, and Structure), and 2029 (Roche, Viking, ...

The greatest disparity in BC-specific survival was observed in women with HR+ HER2− tumors, with Black women having a 50% ...